This section concerns all aspects of endocrine tumours and cancer including, but not limited to: prevention, diagnosis and management, as well as related molecular genetics, and pathophysiology.
The precursor for nerve growth factor (proNGF) is not a serum or biopsy-rinse biomarker for thyroid cancer diagnosis
Nerves and neurotrophic growth factors are emerging promoters of cancer growth. The precursor for Nerve Growth Factor (proNGF) is overexpressed in thyroid cancer, but its potential role as a clinical biomarker...
Citation: BMC Endocrine Disorders 2019 19:128